Filing Details

Accession Number:
0001179110-13-016561
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-14 21:37:35
Reporting Period:
2013-11-12
Filing Date:
2013-11-14
Accepted Time:
2013-11-14 21:37:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1145460 Alere Inc. ALR In Vitro & In Vivo Diagnostic Substances (2835) 043565120
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1208157 T Paul Hempel 51 Sawyer Road, Suite 200
Waltham MA 02453
Svp Ethics & Compliance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-11-12 3,655 $21.78 23,517 No 4 M Direct
Common Stock Disposition 2013-11-12 3,655 $33.75 19,862 No 4 S Direct
Common Stock Acquisiton 2013-11-13 921 $21.78 20,783 No 4 M Direct
Common Stock Disposition 2013-11-13 921 $33.68 19,862 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2013-11-12 3,655 $0.00 3,655 $21.78
Common Stock Employee Stock Option (Right to Buy) Disposition 2013-11-13 921 $0.00 921 $21.78
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
921 2013-12-31 No 4 M Direct
0 2013-12-31 No 4 M Direct
Footnotes
  1. These options became exercisable in four equal annual installments beginning 12/31/2004.
  2. This derivative security does not have a price.
  3. Includes 242 shares acquired under the Alere Inc. Employee Stock Purchase Plan on June 30, 2013.
  4. Represents same day exercise and sale of expiring stock options.